2seventy bio, Inc. financial data

Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q1 2025 - 07 May 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 480% % 15%
Debt-to-equity 123% % 8.9%
Return On Equity -2% % 98%
Return On Assets -1% % 98%
Operating Margin -138% % 59%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52,338,383 shares 2%
Common Stock, Shares, Outstanding 52,465,000 shares 2.1%
Entity Public Float $198,251,396 USD -61%
Common Stock, Value, Issued $5,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 53,055,000 shares 1.9%
Weighted Average Number of Shares Outstanding, Diluted 53,433,000 shares 2.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $48,365,000 USD -32%
Research and Development Expense $38,385,000 USD -81%
Costs and Expenses $115,161,000 USD -63%
Operating Income (Loss) $66,796,000 USD 72%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $4,092,000 USD 98%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $4,092,000 USD 98%
Earnings Per Share, Basic 0 USD/shares 98%
Earnings Per Share, Diluted 0 USD/shares 98%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $92,356,000 USD 63%
Assets, Current $198,582,000 USD -6.7%
Property, Plant and Equipment, Net $32,299,000 USD -16%
Operating Lease, Right-of-Use Asset $199,825,000 USD -7.2%
Intangible Assets, Net (Excluding Goodwill) $5,708,000 USD -11%
Assets $480,005,000 USD -6.1%
Accounts Payable, Current $5,176,000 USD -41%
Employee-related Liabilities, Current $2,420,000 USD -53%
Contract with Customer, Liability, Current $0 USD -100%
Liabilities, Current $41,397,000 USD -31%
Contract with Customer, Liability, Noncurrent $0 USD -100%
Operating Lease, Liability, Noncurrent $223,002,000 USD -7.1%
Other Liabilities, Noncurrent $1,645,000 USD 140%
Liabilities $266,044,000 USD -12%
Accumulated Other Comprehensive Income (Loss), Net of Tax $54,000 USD
Retained Earnings (Accumulated Deficit) $567,982,000 USD -0.73%
Stockholders' Equity Attributable to Parent $213,961,000 USD 3.1%
Liabilities and Equity $480,005,000 USD -6.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $10,973,000 USD 74%
Net Cash Provided by (Used in) Financing Activities $500,000 USD 30%
Net Cash Provided by (Used in) Investing Activities $39,627,000 USD 82%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 52,465,000 shares 2.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $29,154,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $102,019,000 USD 79%
Deferred Tax Assets, Valuation Allowance $195,556,000 USD 8.2%
Deferred Tax Assets, Gross $256,892,000 USD 3%
Operating Lease, Liability $243,717,000 USD -5%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $3,702,000 USD 98%
Lessee, Operating Lease, Liability, to be Paid $312,800,000 USD -8.4%
Property, Plant and Equipment, Gross $63,797,000 USD -1.6%
Operating Lease, Liability, Current $16,761,000 USD 29%
Lessee, Operating Lease, Liability, to be Paid, Year Two $32,920,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid, Year One $29,498,000 USD 2.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $69,083,000 USD -19%
Lessee, Operating Lease, Liability, to be Paid, Year Three $35,086,000 USD 6.6%
Deferred Tax Assets, Operating Loss Carryforwards $61,734,000 USD 60%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $1,912,000 USD 6.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four $33,125,000 USD -5.6%
Additional Paid in Capital $781,884,000 USD 1.3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $1,638,000 USD -22%
Share-based Payment Arrangement, Expense $9,693,000 USD -64%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%